s6y
Company name or ticker
Search
Enliven Therapeutics, Inc.
4
Collins Helen Louise: Statement of changes in beneficial ownership of securities
Filed
Monday, September 21, 2026
Period
Sep 17, 2026
Accession number
0001701247-26-000013
Documents
form4-09212026_090903.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header